Ledger.Open graph →

SEC Form D · filed June 2, 2023

Hopewell Therapeutics, Inc

Offering

$10.0M

Sold

$3.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Woburn, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jake Xia · Woburn, MADirector Xutian V. Jing · Woburn, MADirector Thomas Hennessey · Woburn, MAExec · Director Qiaobing V. Xu · Woburn, MAExec · Director Howard Rosen · Hayward, CADirector Kjiel Carlson · El Segundo, CAExec · Director Brian L. Burns · PHOENIX, AZExec · Director Liat Bycel · San Francisco, CADirector James L. Goulka · PHOENIX, AZDirector Jesse Clurman · BROOKLYN, NYExec · Director C. E. Springman · Bellevue, WAExec · Director Sara Loewel · BROOKLYN, NYDirector David Karandish · St. Louis, MODirector Howard Rosen · St. Paul, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗